New York, New York--(Newsfile Corp. - October 23, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc. ("Alnylam" or the "Company") (NASDAQ:… Read More
Introduction:
The Global RNAi Technology Market, as reported by TechSci Research in their “RNAi Technology Market – Global Industry Size, Share, Trends, Competition Forecast … Read More
CLEVELAND — In a surprise Monday morning move, the FDA declined to expand the indication for anti-amyloid agent patisiran (Onpattro) in treating wild-type or hereditary transthyret… Read More
Nedosiran (Rivfloza), a once-monthly RNA interference (RNAi) injection, gained FDA approval for certain patients with primary hyperoxaluria type 1 (PH1), drugmaker Novo Nordisk announced M… Read More
Detailed industry analysis and market share information are provided in a recent report by Renub Research titled “Huntington Disease Treatment Market, Size, Global Forecast 2023-2030… Read More
The resolution signifies Moderna’s commitment to addressing legal matters transparently and efficiently. By reaching an agreement with Alnylam, Moderna aims to streamline the legal lan… Read More
Global Respiratory Syncytial Virus Therapeutics Market is expected to grow at a CAGR of 31.20% during the forecast period to reach US$ 7001.1 Mn. by 2029.
Market Overview:
The objective… Read More
The primary hyperoxaluria treatment market is driven by the increasing prevalence of PH, advances in medical technology, and growing awareness about the disorder among healthcare professiona… Read More
AMSTERDAM — Semaglutide 2.4 mg (Wegovy) led to clinically meaningful reductions in symptoms and weight among patients with obesity and heart failure with preserved ejection fractio… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hemophilia pipeline constitutes 80+ key companies continuously working towards developing 80+ Hemophili… Read More
The length of siRNA is 7-8 nm, the diameter is 2-3 nm, the molecular weight is 13-14 kDa, and it is hydrophilic. Therefore, unmodified and naked siRNA cannot passively cross the cell membran… Read More
The cell and gene therapy market size is poised to grow by $ 82.24 billion by 2032 from $ 15.46 billion in 2022, exhibiting a CAGR of 18.3% during the forecast period 2023-2032.
Key Takeawa… Read More
Patients with hypertension successfully dialed down their angiotensinogen levels and had lasting reductions in blood pressure (BP) following one injection of an investigational small inter… Read More
Patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes may be at significantly higher risk of hepatic decompensation and liver cancer, researchers reported.
In a meta… Read More
SAN DIEGO — Cardiovascular medications were better optimized for patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) following a multifaceted int… Read More
Existing research shows that nucleic acids can be used for the treatment of neurological diseases, cardiovascular diseases, and cancer, as well as for the prevention of chronic and infectiou… Read More
BioNTech, the German vaccine maker behind the widely used COVID-19 vaccine, is set to appear in court on Monday as it defends itself against the first lawsuit in Germany related to alleged… Read More
The Global Regenerative Medicine Market in terms of revenue was estimated to be worth $12.2 Billion in 2022 and is poised to grow at a CAGR of 27.2% from 2022 to 2027. Market growth is drive… Read More
The cell and gene therapy market would grow at a CAGR of 22.41% over the predicted time frame. The market is expected to increase in value from US$ 18.61 Bn in 2022 to US$ 93.78 Bn in 2… Read More
The Global Gene Therapy Market is projected to reach USD 17.2 billion by 2027 from USD 7.3 billion in 2022, at a CAGR of 18.6% during the forecast period. The lucrative growth is a… Read More
The financial world saw a surge of initial public offerings (IPOs) in 2004, capturing the attention of investors, analysts, and the media alike. The year was busy for companies looking to go… Read More
The mRNA therapeutics market would grow at a CAGR of 13.03% over the predicted time frame. The market is expected to increase in value from US$ 48.1 Bn in 2022 to US$ 128.14 Bn in 2030.
The… Read More
Gene Therapy Market in terms of revenue was estimated to be worth $7.3 billion in 2022 and is poised to reach $17.2 billion by 2027, growing at a CAGR of 18.6% from 2022 to 2027. Factor… Read More